Search research articles
Contact Us
Filters
Showing results (131-140 of 153) with videos related to
Page
of 16
Sort By:
Diabetes Care
|
July 13, 2021
Atherogenic Dyslipidemia on Admission Is Associated With Poorer Outcome in People With and Without Diabetes Hospitalized for COVID-19
Alfonso Bellia, Aikaterini Andreadi, Luca Giudice, et al.
Acta Cardiologica
|
March 20, 2014
Coronary artery disease. A study of three polymorphic sites of adenosine deaminase gene
Patrizia Saccucci, Agnieszka Binczak-Kuleta, Maria Banci, et al.
Journal of Nanoscience and Nanotechnology
|
June 25, 2008
Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassemblies
Matthew H Cato, Federica D'Annibale, David M Mills, et al.
Brain, Behavior, and Immunity
|
May 17, 2020
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Claudio Liguori, Mariangela Pierantozzi, Matteo Spanetta, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2022
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study
Maria Albanese, Giulia Marrone, Agostino Paolino, et al.
Acta Diabetologica
|
August 31, 2022
Impact of light therapy on rotating night shift workers: the EuRhythDia study
Stefano Rizza, Alessio Luzi, Maria Mavilio, et al.
Acta Diabetologica
|
March 31, 2021
Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study
Stefano Rizza, Alessio Luzi, Maria Mavilio, et al.
Endocrine
|
November 9, 2022
Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19
Alessandro Minasi, Aikaterini Andreadi, Alessio Maiorino, et al.
Nano Letters
|
September 22, 2018
Fluorinated Oligoethylenimine Nanoassemblies for Efficient siRNA-Mediated Gene Silencing in Serum-Containing Media by Effective Endosomal Escape
Tingbin Zhang, Yuanyu Huang, Xiaowei Ma, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 30, 2021
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
Annalisa Noce, Maria Albanese, Giulia Marrone, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 153) with videos related to
Sort By:
Page
of 16
Diabetes Care
|
July 13, 2021
Atherogenic Dyslipidemia on Admission Is Associated With Poorer Outcome in People With and Without Diabetes Hospitalized for COVID-19
Alfonso Bellia, Aikaterini Andreadi, Luca Giudice, et al.
Acta Cardiologica
|
March 20, 2014
Coronary artery disease. A study of three polymorphic sites of adenosine deaminase gene
Patrizia Saccucci, Agnieszka Binczak-Kuleta, Maria Banci, et al.
Journal of Nanoscience and Nanotechnology
|
June 25, 2008
Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassemblies
Matthew H Cato, Federica D'Annibale, David M Mills, et al.
Brain, Behavior, and Immunity
|
May 17, 2020
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Claudio Liguori, Mariangela Pierantozzi, Matteo Spanetta, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2022
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study
Maria Albanese, Giulia Marrone, Agostino Paolino, et al.
Acta Diabetologica
|
August 31, 2022
Impact of light therapy on rotating night shift workers: the EuRhythDia study
Stefano Rizza, Alessio Luzi, Maria Mavilio, et al.
Acta Diabetologica
|
March 31, 2021
Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study
Stefano Rizza, Alessio Luzi, Maria Mavilio, et al.
Endocrine
|
November 9, 2022
Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19
Alessandro Minasi, Aikaterini Andreadi, Alessio Maiorino, et al.
Nano Letters
|
September 22, 2018
Fluorinated Oligoethylenimine Nanoassemblies for Efficient siRNA-Mediated Gene Silencing in Serum-Containing Media by Effective Endosomal Escape
Tingbin Zhang, Yuanyu Huang, Xiaowei Ma, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 30, 2021
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
Annalisa Noce, Maria Albanese, Giulia Marrone, et al.
Page
of 16